دورية أكاديمية
Hepatitis B Seroprevalence Study 1999.
| العنوان: | Hepatitis B Seroprevalence Study 1999. |
|---|---|
| المؤلفون: | James L; Communicable Diseases Branch, Epidemiology and Disease Control Division, Ministry of Health, Singapore. Lyn_JAMES@moh.gov.sg, Fong CW, Foong BH, Wee MK, Chow A, Shum E, Chew SK |
| المصدر: | Singapore medical journal [Singapore Med J] 2001 Sep; Vol. 42 (9), pp. 420-4. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Wolters Kluwer - Medknow Country of Publication: India NLM ID: 0404516 Publication Model: Print Cited Medium: Print ISSN: 0037-5675 (Print) Linking ISSN: 00375675 NLM ISO Abbreviation: Singapore Med J Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: July 2022- : [Mumbai] : Wolters Kluwer - Medknow Original Publication: Singapore, Singapore Medical Assn. |
| مواضيع طبية MeSH: | Hepatitis B/*epidemiology, Adolescent ; Adult ; Aged ; Cross-Sectional Studies ; Female ; Hepatitis B/prevention & control ; Hepatitis B Antibodies/blood ; Hepatitis B Surface Antigens/blood ; Hepatitis B e Antigens/blood ; Humans ; Immunization Programs/standards ; Male ; Middle Aged ; Seroepidemiologic Studies ; Singapore/epidemiology |
| مستخلص: | Hepatitis B is a disease of public health importance in Singapore. A study was conducted in 1999 to estimate the overall and gender-, age- and ethnic-specific prevalence of hepatitis B surface antigen (HBsAg), hepatitis B e antigen (HBeAg) and antibody to hepatitis B surface antigen in the Singapore population. A cross-sectional sample of the Singapore population constituting 4,698 Singapore residents aged 18-69 years was surveyed. This was the first time a large-scale study has been conducted to assess the hepatitis B seroprevalence rates in the Singapore population. The overall prevalence of the HBsAg in the general population was estimated to be about 4%. About 13% of the HBsAg carriers were also HBeAg positive. Only about 40% of the population had immunity to hepatitis B virus either through immunisation or from previous exposure to the virus. There was still a large proportion (60%) of the population who had no immunity, especially the younger age group of 18-29 years where only 28% had immunity. There is a need to strengthen the hepatitis B immunisation programme to reach out to those who have no immunity, especially the young adults. |
| المشرفين على المادة: | 0 (Hepatitis B Antibodies) 0 (Hepatitis B Surface Antigens) 0 (Hepatitis B e Antigens) |
| تواريخ الأحداث: | Date Created: 20020129 Date Completed: 20020304 Latest Revision: 20091103 |
| رمز التحديث: | 20221213 |
| PMID: | 11811609 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 0037-5675 |
|---|